A Clinical Study on Causticum 200 Centesimal Potency in Primary Enuresis
PE
A CLINICAL STUDY TO EVALUATE THE EFFICACY OF CAUSTICUM 200C IN THE TREATMENT OF PRIMARY ENURESIS
1 other identifier
interventional
50
1 country
1
Brief Summary
Homeopathic Medicine Causticum 200c will be prescribed in cases of Primary Enuresis on the basis of available symptoms for a period of one year and the results will be evaluated at the end of the given period and efficacy of the drug will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started May 2014
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 30, 2014
CompletedFirst Posted
Study publicly available on registry
June 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedJune 3, 2014
May 1, 2014
1 year
May 30, 2014
June 2, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bring down frequency of bed wetting
The patients with nocturnal enuresis will receive causticum 200c on weekly basis and results expected by one month.
1month
Study Arms (1)
Homoeopathic Medicine Causticum
EXPERIMENTALThe drug namely Causticum 200C potency shall be administered as 4 globules, prescribed once a week for 3 months with placebo to follow for the remaining period.
Interventions
Eligibility Criteria
You may qualify if:
- Age group between 5-15 yrs
- Both sexes are included
- Patients with Primary enuresis will be Included
- Patients with Nocturnal or Diurnal enuresis will be included
You may not qualify if:
- Patients with metabolic illness like Diabetes Mellitus or Diabetes Insipidus will be excluded
- Congenital anomalies like horse shoe kidney, polycystic kidney will be excluded.
- Presence of Malignancy, Mental Retardation and Cerebral palsy will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Father Muller Homoeopathic Medical College
Mangalore, Karnataka, 575018, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jyoshna Shivaprasad, MD (Hom)
Father Muller Homoeopathic Medical College
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr Jyoshna Shivaprasad
Study Record Dates
First Submitted
May 30, 2014
First Posted
June 3, 2014
Study Start
May 1, 2014
Primary Completion
May 1, 2015
Study Completion
August 1, 2015
Last Updated
June 3, 2014
Record last verified: 2014-05